@dermatologyadvisor.bsky.socialImprovements in both investigator- and patient-reported outcomes were observed at 12 months of treatment with #tralokinumab for #AtopicDermatitis, with no new safety signals identified.
Read more: https://www.dermatologyadvisor.com/news/real-world-results-confirms-efficacy-safety-tralokinumab-ad/
@allergyasthmahq.bsky.socialThis medicine is still being studied and is not yet approved. A Phase 2b trial of a version given as an injection under the skin (subcutaneous) is planned for mid-2027.
Read the full press release from Evommune: ir.evommune.com/news-events/...
@healioguidance.bsky.social🔎Treating patients with atopic dermatitis?
We have what you need to know.
Use our module to help you:
• evaluate environmental risk factors;
• implement phototherapy or oral systemic therapy; and
• review treatment guidelines.
@optometryadvisor.bsky.socialPatients with moderate-to-severe #AtopicDermatitis treated with #Dupilumab may have elevated risk of developing ocular adverse effects, particularly those affecting the ocular surface, according to research published in Clinical Science.
Learn more: https://bit.ly/47BRIGJ
@thejidinnovations.bsky.socialRead the review article by Wu et al:
Current research landscape and future prospects of in silico modeling approaches for #atopicdermatitis
https://doi.org/10.1016/j.xjidi.2026.100513
#DermatologyJournal #Dermatology #derm #dermatologist #dermresearch #dermscience #dermatologyresearch
@antibodytx.bsky.socialAntibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Research Highlight - GB12-09, a bispecific antibody targeting IL4Rα and IL31Rα for atopic dermatitis therapy.
doi.org/10.1093/abt/...
#bispecificantibodies #bsab #bsabs #atopicdermatitis #th2cytokines #il4rα #il31rα
@dermatologyadvisor.bsky.social#Dupilumab therapy in pediatric patients with moderate to severe #AtopicDermatitis is associated with meaningful increases in weight & #BMI. #EADV2026
@pharmaphorum.bsky.social#AbbVie's long-acting anti-IL-13 antibody #zumilokibart – the main asset in its $10.9 billion takeover of Apogee Therapeutics – has hit the mark in a phase 2b trial in #atopicdermatitis, its lead indication.
@singsongraptor.bsky.socialCan anyone give recommendations on a hypoallergenic liquid hand soap? Bonus if there's a portable version I could take to school? I'll put it in a bottle with a flip cap if I have to
@dermimmuno.bsky.socialIn a phase 3 trial, #ivarmacitinib was associated with improved skin signs and itch for adolescents and adults with moderate to severe #AtopicDermatitis. #Dermatology
🌟 Read the full article here:
www.docwirenews.com/post/long-te...
@dermatologyadvisor.bsky.socialIn children with moderate to severe #AtopicDermatitis, 62% of boys and 48% of girls were below the 50th percentile for height, whereas 50% and 51%, were above the 50th percentile for weight.
@kill-bait.bsky.socialEarly Skin Microbiome Changes Are Associated With Later Atopic Disease in Infants
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
#skinmicrobiome #atopicdermatitis #infants
👇👇👇
@aafanational.bsky.socialClinicians: Earn Free #CME credit on #AtopicDermatitis (AD). Topics discussed:
➡️ How long-term management of AD is essential for improving outcomes
➡️ Advanced therapies to manage AD
➡️ Improving treatment adherence and outcomes
Watch now: https://bit.ly/4vlPZ1T
@swhr.bsky.social#AtopicDermatitis, a form of #eczema, causes more than dry, itchy skin – it can also put individuals at a higher risk of #anxiety and #depression. During #NationalEczemaWeek, learn more about this #ChronicDisease in our fact sheet: https://ow.ly/tjs050ZLxIc. #SWHRtalksAutoimmune
@charityeos.bsky.socialRead the 2026 study insights
👉 https://ow.ly/WSQz50ZIjnt This #WorldAtopicEczemaDay , we’re highlighting new research exploring the connection between #atopicdermatitis and #eosinophilicesophagitis. Discover why this connection matters. #BreakTheInvisibleBurden #SkinAllergy
@allergy-eaaci.bsky.social#Atopicdermatitis, also known as eczematous dermatitis and atopic #eczema, is a skin disease characterized by extremely itchy and irritated skin that poses a great burden to the patient.
@allergy-eaaci.bsky.socialOpen access: Serum‐Proteomic Profiling Reveals Distinct #AtopicDermatitis Severity‐Linked Signatures. First author: Jag S. Lally; corresponding author: Anna De Benedetto
👉 doi.org/10.1111/all.70464
#Allergy_journal
More articles 👉 journalallergy.com/Atopic_Dermatitis_Urticaria_and_Skin_Disease
@apcmicrobiomeirel.bsky.socialThree environmental, immune & gene activity patterns were linked with eczema in 217 children. New in @plosmedicine.org, with APC researchers.
Read: buff.ly/m7qZC5h
APC: buff.ly/IyoMZoV
#AtopicDermatitis #Eczema #MachineLearning #Immunology #Immunosky
@plosmedicine.org @uccmicrobiology.bsky.social
@dermatologyadvisor.bsky.socialAdherence to 4 healthy lifestyle behaviors was associated with a lower incidence of adult-onset #AtopicDermatitis when compared with those who adhered to 0 or 1 behavior.
@sevapediatrics.bsky.social